Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025
Sight Sciences (SGHT) has announced it will release its fourth quarter and full year 2024 financial results after market close on March 5, 2025. The eyecare technology company will host a conference call to discuss the results at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day. Investors can access the live webcast and replay of the event through the company's website at www.sightsciences.com in the Investors page under News & Events section. The webcast replay will be available for at least 90 days following the event.
Sight Sciences (SGHT) ha annunciato che pubblicherà i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 dopo la chiusura del mercato il 5 marzo 2025. L'azienda tecnologica nel settore dell'eyecare ospiterà una conferenza telefonica per discutere i risultati alle 13:30 ora del Pacifico / 16:30 ora dell'Est dello stesso giorno. Gli investitori possono accedere alla diretta e alla registrazione dell'evento attraverso il sito web dell'azienda all'indirizzo www.sightsciences.com nella pagina per gli investitori nella sezione Notizie ed Eventi. La registrazione della diretta sarà disponibile per almeno 90 giorni dopo l'evento.
Sight Sciences (SGHT) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año completo 2024 después del cierre del mercado el 5 de marzo de 2025. La empresa de tecnología en el cuidado de los ojos llevará a cabo una conferencia telefónica para discutir los resultados a la 1:30 p.m. hora del Pacífico / 4:30 p.m. hora del Este del mismo día. Los inversores pueden acceder a la transmisión en vivo y a la repetición del evento a través del sitio web de la empresa en www.sightsciences.com en la página de Inversores bajo la sección de Noticias y Eventos. La repetición de la transmisión estará disponible durante al menos 90 días después del evento.
Sight Sciences (SGHT)는 2024년 4분기 및 연간 재무 결과를 2025년 3월 5일 시장 마감 후 발표할 것이라고 발표했습니다. 안과 기술 회사는 같은 날 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 결과에 대해 논의하는 전화 회의를 개최합니다. 투자자들은 회사 웹사이트 www.sightsciences.com의 투자자 페이지의 뉴스 및 이벤트 섹션을 통해 실시간 웹캐스트 및 이벤트 재생에 접근할 수 있습니다. 웹캐스트 재생은 이벤트 이후 최소 90일 동안 제공됩니다.
Sight Sciences (SGHT) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'année entière 2024 après la clôture des marchés le 5 mars 2025. L'entreprise de technologie de soins oculaires organisera une conférence téléphonique pour discuter des résultats à 13h30 heure du Pacifique / 16h30 heure de l'Est le même jour. Les investisseurs peuvent accéder à la diffusion en direct et à la rediffusion de l'événement via le site web de l'entreprise à l'adresse www.sightsciences.com sur la page des investisseurs dans la section Actualités et Événements. La rediffusion sera disponible pendant au moins 90 jours après l'événement.
Sight Sciences (SGHT) hat angekündigt, dass es seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 nach Börsenschluss am 5. März 2025 veröffentlichen wird. Das Unternehmen für Augentechnologie wird am selben Tag um 13:30 Uhr Pazifische Zeit / 16:30 Uhr Ostzeit eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können über die Website des Unternehmens unter www.sightsciences.com auf die Live-Übertragung und die Wiederholung der Veranstaltung zugreifen, die sich im Bereich Investoren unter Nachrichten & Veranstaltungen befindet. Die Wiederholung der Übertragung wird mindestens 90 Tage nach der Veranstaltung verfügbar sein.
- None.
- None.
MENLO PARK, Calif., Feb. 19, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing innovative technology intended to transform care and improve patients’ lives, today announced it will report financial results for the fourth quarter and full year ended December 31, 2024, after the market close on Wednesday, March 5, 2025. The Company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.sightsciences.com, on the Investors page in the News & Events section. The webcast will be available for replay for at least 90 days after the event.
About Sight Sciences
Sight Sciences is an eyecare technology company focused on developing and commercializing innovative and interventional solutions intended to transform care and improve patients’ lives. Using minimally invasive or non-invasive approaches to target the underlying causes of the world’s most prevalent eye diseases, Sight Sciences seeks to create more effective treatment paradigms that enhance patient care and supplant conventional outdated approaches. The Company’s OMNI® Surgical System is an implant-free glaucoma surgery technology (i) indicated in the United States to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and (ii) CE Marked for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma. Glaucoma is the world’s leading cause of irreversible blindness. The SION® Surgical Instrument is a bladeless, manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The Company’s TearCare® System is 510(k) cleared in the United States for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (“MGD”), enabling clearance of gland obstructions by physicians to address the leading cause of dry eye disease. Visit www.sightsciences.com for more information.
Sight Sciences, the Sight Sciences logo, TearCare, SmartHub and SmartLids are trademarks of Sight Sciences registered in the United States. OMNI and SION are trademarks of Sight Sciences registered in the United States, European Union and other territories.
© 2025 Sight Sciences. All rights reserved.
Media contact:
pr@sightsciences.com
Investor contact:
Philip Taylor
Gilmartin Group
415.937.5406
investor.relations@sightsciences.com
FAQ
When will Sight Sciences (SGHT) report Q4 and full year 2024 earnings?
What time is Sight Sciences (SGHT) Q4 2024 earnings call?
How can investors access Sight Sciences (SGHT) Q4 2024 earnings call?
How long will Sight Sciences (SGHT) Q4 2024 earnings webcast be available for replay?
